Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
23
datasets available to search
ShareScore release 0.9.0
Dataset results
23 results for “DLL3”
Study Comparing Rovalpituzumab Tesirine Versus Topotecan in Subjects With Advanced or Metastatic Small Cell Lung Cancer With High Levels of Delta-like Protein 3 (DLL3) and Who Have First Disease Progr
ClinicalTrials.gov study NCT03061812. IPD Sharing: YES. Countries: 33. Publications: 2.
A Study to Test Different Doses of BI 764532 in Patients With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3
ClinicalTrials.gov study NCT04429087. IPD Sharing: YES. Countries: 4. Publications: 1.
Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
ClinicalTrials.gov study NCT07006727. IPD Sharing: NO. Countries: 3. Publications: 0.
DLL3 CAR-T Therapy Targeting Brain Tumors
ClinicalTrials.gov study NCT07180927. IPD Sharing: NO. Countries: 1. Publications: 0.
DLL3-Directed Chimeric Antigen Receptor T-cells in Subjects With Extensive Stage Small Cell Lung Cancer
ClinicalTrials.gov study NCT05680922. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of DLL3-CAR-NK Cells in the Treatment of Extensive Stage Small Cell Lung Cancer
ClinicalTrials.gov study NCT05507593. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
ClinicalTrials.gov study NCT07174583. IPD Sharing: Not stated. Countries: 7. Publications: 0.
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
ClinicalTrials.gov study NCT05652686. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
TC-D101 Cell Therapy for Patients With DLL3-Positive SCLC
ClinicalTrials.gov study NCT07246304. IPD Sharing: NO. Countries: 1. Publications: 0.
Tarlatamab in Advanced Delta-like 3 (DLL3)-Expressing Tumors Including Neuroendocrine Neoplasms
ClinicalTrials.gov study NCT06788938. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That is Positive for DLL3
ClinicalTrials.gov study NCT05916313. IPD Sharing: NO. Countries: 6. Publications: 0.
Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
ClinicalTrials.gov study NCT06814496. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
ClinicalTrials.gov study NCT07278479. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study in Participants With Advanced Cancers Associated With Expression of DLL3 (MK-6070-001/HPN328-4001)
ClinicalTrials.gov study NCT04471727. IPD Sharing: YES. Countries: 1. Publications: 0.
NG2 and DLL3 CAR-T Cells Targeting Melanoma
ClinicalTrials.gov study NCT07193966. IPD Sharing: NO. Countries: 1. Publications: 0.
This Study is an Open-lable, Phase I Study to Evaluate the Safety, Feasibility, Cytokinetics, and Preliminary Efficacy of GC511B in DLL3+ Relapsed/Refractory Small Cell Lung Cancer.
ClinicalTrials.gov study NCT07249879. IPD Sharing: NO. Countries: 1. Publications: 0.
Recapitulating the Human Segmentation Clock with Pluripotent Stem Cells - RNAseq analysis of healthy control (WT) and knock-out reporter lines of segmentation clock genes HES7, DLL3, LFNG and MESP2.
GEO Series GSE116930. Homo sapiens. 24 samples. Type: Expression profiling by high throughput sequencing.
MOE430A Analysis of Dll3 mutant vs. wild-type 9.5 dpc presomitic mesoderm
GEO Series GSE15152. Mus musculus. 6 samples. Type: Expression profiling by array.
MOE430A Analysis of Dll3 mutant vs. wild-type 9.5 dpc somite-level tissue
GEO Series GSE15153. Mus musculus. 6 samples. Type: Expression profiling by array.
Imaging of Solid Tumors Using DLL3 SPECT
ClinicalTrials.gov study NCT07052760. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.